The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 EnvelopeMark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al.|The Journal of Immunology|2012Cited by 140